BY Maria Outze

Previous FDA manager Scott Gottlieb questions that Hims & Hers will certainly be permitted to offer its replica of Novo Nordisk’s weight-loss tablet computer.

The Danish pharmaceutical firm obtained 150 problems regarding harassment and discrimination in 2014.

Lundbeck’s most significant item is dealing with even more competitors and raised cost stress in the United States. According to the firm’s chief executive officer, Lun…

chief executive officer Charl van Zyl obtained simply under DKK 1 million (USD 157,990) a lot more in overall settlement in 2025 after traditionally high earnings.

The FDA will certainly “take speedy activity” versus business marketing “unlawful imitator medicines,” states FDA commissioner. The news follows Hims &…

Lundbeck is “out track” in regards to minimizing carbon dioxide exhausts from its vendors, however has actually made development in minimizing its very own straight exh…

After Lundbeck took out from the fight for Irish firm Avadel in the loss, chief executive officer Charl van Zyl remains to try to find brand-new purchases. However the firm is &#82…

Drug business can conserve a great deal of money and time by utilizing AI. Nonetheless, the globe has yet to see an AI-derived medicine struck the marketplace. There are indication…

Lundbeck recognizes CMS’ choice that the business’s very popular medicine, Rexulti, has actually been picked for rate settlements under among the biggest medical insura…